Core Viewpoint - The oral care industry is undergoing a transformation driven by increasing consumer awareness of oral health, with "professionalism" emerging as a new trend. Dengkang Oral (001328.SZ) is transitioning from a single product focus to an oral health ecosystem, leveraging its competitive edge in the sensitive toothpaste segment [4]. Group 1: Company Overview and Market Position - Dengkang Oral was established in 1999 and specializes in the research and sales of oral care products, with toothpaste being its core category. The company has a strong competitive advantage due to its unique sensitive technology, including dual sensitivity technology and bio-glass ceramic materials, which effectively address tooth sensitivity [5]. - Since 2021, Dengkang Oral has maintained over 60% market share in the sensitive toothpaste segment, reaching a new high of 64.7% in 2024 [5]. Group 2: Research and Development - The company's differentiation advantage stems from its continuous investment in research and development, with R&D expense ratios consistently between 3.0% and 3.5%, significantly higher than the industry average [8]. - As of mid-2025, Dengkang Oral has authorized over 260 domestic patents, including more than 30 invention patents, and has participated in drafting national and industry standards [10]. Group 3: Product Strategy and Financial Performance - Dengkang Oral is focusing on high-end product iterations and channel promotion, with products like the "Medical Research 7-Day Repair Toothpaste" priced at 39.9 yuan, double that of traditional products. The new "Recombinant Protein" series, priced at 49.9 yuan, achieved sales of 4.89 million yuan on Douyin in September, ranking first in its category [12]. - The sales proportion of mid-to-high-end toothpaste products reached approximately 40% in the first half of 2025, contributing to improved profitability, with a gross margin of 49.4% in 2024, up 5.3 percentage points year-on-year, and further increasing to 50.5% in the first three quarters of 2025 [12]. Group 4: Strategic Expansion Plans - In December 2025, Dengkang Oral announced its "8462 Leap Action - 14th Five-Year Plan," aiming to expand into four key areas: oral care, smart oral, oral medical, and innovative businesses [20]. - The company plans to invest approximately 113 million yuan by 2026 to focus on the oral health ecosystem, with a goal of doubling revenue and profit during the 14th Five-Year period [22][23]. - As of the third quarter of 2025, Dengkang Oral had cash and cash equivalents totaling nearly 1.5 billion yuan, providing a solid financial foundation for its business upgrades [25].

Investment Rating - The investment rating for the company is "Accumulate" [7] Core Insights - The company has announced its 2026 investment plan and the "8462 Leap Action - 14th Five-Year Plan," clarifying its growth direction for the future [1] - The company aims to enhance its "digital intelligence" capabilities and accelerate the layout of the oral health ecosystem, with planned investments of approximately 113 million yuan, including 63 million yuan in fixed assets and 50 million yuan in equity investments [2] - The company has set ambitious goals to double both revenue and total profit during the 14th Five-Year Plan, focusing on four key areas: oral care, smart oral health, oral medical services, and innovative businesses [3] - The company is expected to recover online investments and achieve a strong start in the 14th Five-Year Plan, with a focus on new product launches and optimizing product structure [4] - The company is a leader in the sensitive toothpaste market and is expected to see substantial growth through product upgrades and diversification, with projected revenues of 1.75 billion yuan, 2.11 billion yuan, and 2.50 billion yuan for 2025, 2026, and 2027, respectively [5] Financial Summary - The company forecasts revenues of 1.75 billion yuan for 2025, with a year-on-year growth of 12.20%, and net profits of 181 million yuan, reflecting a growth of 12.50% [11] - For 2026, the expected revenue is 2.11 billion yuan, with a growth rate of 20.67%, and net profit is projected at 219 million yuan, a 20.96% increase [11] - By 2027, the company anticipates revenues of 2.50 billion yuan, with an 18.43% growth, and net profits of 263 million yuan, reflecting a 19.89% increase [11]